Shahin Gharakhanian

MD, DPH

Speciality: Chief Medical Officer
Company: DECOY Therapeutics
Designation: SAB Chair

Personal Information

Shahin Gharakhanian, MD, DTM&H, DPH, is Chair, Scientific Advisory Board of Cambridge MA-based DECOY Therapeutics & the Chief Medical Officer. He is a Physician-Executive with expertise in Pharmaceutical Medicine, Leadership/Management, and an international track record both in Clinical Medicine and Pharmaceutical Medicine Including Vice-President of Vertex Pharmaceuticals Inc. in Boston/Cambridge MA, USA, Global R&D group and Corporate Operating Council Member. Overall, clinically developed/launched four novel treatments including a first-in-class Direct Acting Antiviral in chronic Hepatitis C (HCV).

His biopharmaceutical R&D or academic research includes Antibiotics, Malaria, Microbiomes, Tuberculosis, Viral infections [AIDS/HIV infection, HBV, HCV, Influenza, RSV]. Dr Gharakhanian is a member of the IAS: International AIDS Society, IDSA: Infectious Diseases Society of America, & SPILF: French-language Infectious Diseases Society. Shahin Gharakhanian’s medical education has been at Paris-Sorbonne University Medical Schools & Hospitals and at Harvard Medical School CME Programs.

Scientia Meetings

Connecting Minds for Scientific Progress!

Join us in revolutionizing conferences! Scientia Meetings is launching events across the country, offering a unique platform for scientists and researchers to share knowledge, explore innovative ideas, and foster collaborations. Buy Ticket